| Original language | English |
|---|---|
| Pages (from-to) | 1064-1078 |
| Number of pages | 15 |
| Journal | Nature Microbiology |
| Volume | 8 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - May 2023 |
| Publication type | A1 Journal article-refereed |
Funding
The study was funded in part by the Novo Nordisk Foundation (NNF21SA0072102); the Center for Microbiome Informatics and Therapeutics (R.J.X.); NIH grant DK043351 (R.J.X.); and NIH grant DK120485 (R.J.X.). J.J. and S.R. were supported by the Novo Nordisk Foundation (grant NNF14CC0001). K.H., K.A. and Y.A. were supported by Moonshot Research and Development Program (JP22zf0127007) and NeDDTrim (JP21ae0121041) from AMED Japan. K.H. and K.A. were supported by MEXT Japan World Premier International Research Center Initiative (WPI). The EDIA study was supported by NIH grant 1DP3DK094338-01 (M.K.) and by the Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research No. 250114 (M.K.).
Publication forum classification
- Publication forum level 3
ASJC Scopus subject areas
- Microbiology
- Immunology
- Applied Microbiology and Biotechnology
- Genetics
- Microbiology (medical)
- Cell Biology
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver